Skip to Content

Join the 'Bladder Cancer' group to help and get support from people like you.

Bladder Cancer News

Related terms: Cancer, Bladder

Report: Industry Hid Decades-Old Study Showing Sugar's Unhealthy Effects

Posted 21 Nov 2017 by Drugs.com

TUESDAY, Nov. 21, 2017 – Big Sugar seems to have copied the Big Tobacco playbook, a new report contends. More than four decades ago, a study in rats funded by the sugar industry found evidence linking the sweetener to heart disease and bladder cancer, the paper trail investigation reports. The results of that study were never made public. Instead, the sugar industry pulled the plug on the study ...

Patients' Gut Bugs May Play Role in Cancer Care

Posted 3 Nov 2017 by Drugs.com

THURSDAY, Nov. 2, 2017 – The type of bacteria that cancer patients harbor in the gut might affect their odds of responding to certain treatments, two early studies hint. The research, in humans and mice, adds to evidence that gut bacteria play a key role in the immune system. But experts stressed it's too soon to make recommendations to cancer patients – including whether they should take ...

Tighter Rules on Arsenic in Water Saved Lives: Study

Posted 23 Oct 2017 by Drugs.com

MONDAY, Oct. 23, 2017 – U.S. government limits on arsenic in drinking water has likely averted hundreds of cases of lung and bladder cancer annually, a new study suggests. After the Environmental Protection Agency introduced tighter limits on arsenic in public drinking water in 2006, there was a 17 percent decrease in levels of arsenic in the urine of people served by public water systems that ...

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 27 Jul 2017 by Drugs.com

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris ...

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In ...

Could Certain Hair Dyes, Relaxers Raise Breast Cancer Risk?

Posted 20 Jun 2017 by Drugs.com

TUESDAY, June 20, 2017 – The safety of hair products has been debated for years. Now, new research suggests that black women who use dark hair dyes face a higher risk of breast cancer, while chemical relaxers and straighteners boost the odds in white women. The findings stem from a study of more than 4,000 women. Use of dark brown or black hair dyes by black women was tied to a 51 percent ...

'Couch Potatoes' May Face Higher Risk of Kidney, Bladder Cancers

Posted 15 Jun 2017 by Drugs.com

THURSDAY, June 15, 2017 – Add greater risk of kidney and bladder cancer to the long list of why a lifetime of sitting on the sofa isn't good for your health, a new study suggests. Specifically, lifetime recreational inactivity was associated with a 73 percent increased risk of bladder cancer and a 77 percent increased risk of kidney cancer. The findings add to growing evidence that inactivity ...

E-Cigarettes Linked to Bladder Cancer Risk

Posted 15 May 2017 by Drugs.com

MONDAY, May 15, 2017 – Although many people think "vaping" is safer than smoking, research suggests that both e-cigarettes and traditional cigarettes are tied to an increased risk for bladder cancer. "We've known traditional smoking raises bladder cancer risk, and given the surge in popularity of e-cigarettes, it's imperative we uncover any potential links" between e-cigarettes and bladder ...

AstraZeneca’s Imfinzi (durvalumab) Receives FDA Accelerated Approval for Previously Treated Patients with Advanced Bladder Cancer

Posted 1 May 2017 by Drugs.com

May 1, 2017 – AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has granted accelerated approval to Imfinzi (durvalumab). Imfinzi is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma (mUC) who have disease progression during or following platinum-containing ...

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and ...

Cancer Survivors Gain From Web-Based Health Care

Posted 10 Feb 2017 by Drugs.com

FRIDAY, Feb. 10, 2017 – Online- and phone-based health care offers a number of benefits for cancer survivors, British researchers report. The new study looked at previous research on cancer survivors' experiences with online and phone health contacts – what the researchers call telehealth. The review found that patients liked the flexibility and convenience of this method of staying in touch ...

Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) in Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma

Posted 10 Feb 2017 by Drugs.com

PRINCETON, N.J.--(BUSINESS WIRE)-- February 2, 2017 – Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has approved Opdivo injection, for intravenous use for the treatment of patients with locally advanced or metastatic urothelial carcinoma (mUC) who have disease progression during or following platinum-containing chemotherapy or have disease ...

Cancer Advances Demand Continual Funding, Specialists Say

Posted 29 Nov 2016 by Drugs.com

TUESDAY, Nov. 29, 2016 – Sufficient and sustained funding for cancer research should be a global priority, European and American cancer organizations said at the start of an international oncology conference in Germany on Tuesday. Significant progress has been made in the understanding of how cancer develops. But, consistent research funding is needed to take advantage of these advances to ...

Low Vitamin D Levels May Raise Bladder Cancer Risk: Study

Posted 8 Nov 2016 by Drugs.com

TUESDAY, Nov. 8, 2016 – Low vitamin D levels may increase the risk of bladder cancer, researchers report. Five of seven studies the researchers reviewed linked low vitamin D levels with an higher risk of bladder cancer. In experiments with the cells that line the bladder, the researchers found that the cells activate and respond to vitamin D. This, in turn, can stimulate an immune response, the ...

Cancer Patients in Poorer Countries Often Go Without Radiation

Posted 2 Oct 2016 by Drugs.com

THURSDAY, Sept. 29, 2016 – Many cancer patients in low- and middle-income nations who would benefit from radiation treatment don't receive it, a new study finds. "In Ghana and the Philippines, for example, about eight in 10 cancer patients who need radiation therapy will not receive needed treatment," said study co-author Dr. Elena Fidarova, a researcher at the International Atomic Energy Agency ...

Page 1 2 3 4 5 Next

Ask a Question

Further Information

Related Condition Support Groups

Urothelial Carcinoma, Cancer

Related Drug Support Groups

methotrexate, cisplatin, cyclophosphamide, doxorubicin, Tecentriq, mitomycin, Adriamycin, Platinol, thiotepa, view more... atezolizumab, Mutamycin, Platinol-AQ, Adriamycin RDF, Thioplex, Adriamycin PFS, Tepadina